• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Ann H. Partridge, MD, MPH


  • Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Bober SL, Kereakoglow S, Borges VF, Come SE, Schapira L, Partridge AH.Treatment-related amenorrhea and sexual functioning in young breast cancer survivors.Cancer. 2014 May 28.
  • Rosenberg SM, Partridge AH.Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making.JAMA Surg. 2014 May 21.
  • Stanton AL, Petrie KJ, Partridge AH.Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.Breast Cancer Res Treat. 2014 Jun;145(2):525-34.
  • Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA, Costa A, Delaloge S, Freilich G, Gentilini OD, Harbeck N, Kelly CM, Loibl S, Meirow D, Peccatori F, Kaufmann B, Cardoso F.First international consensus guidelines for breast cancer in young women (BCY1).Breast. 2014 Apr 23.
  • Gropper AB, Calvillo KZ, Dominici L, Troyan S, Rhei E, Economy KE, Tung NM, Schapira L, Meisel JL, Partridge AH, Mayer EL.Sentinel Lymph Node Biopsy in Pregnant Women with Breast Cancer.Ann Surg Oncol. 2014 Apr 23.
  • Andersen BL, Derubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH.Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation.J Clin Oncol. 2014 Apr 14.
  • Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, Borges VF, Meyer ME, Partridge AH.Prospective study of fertility concerns and preservation strategies in young women with breast cancer.J Clin Oncol. 2014 Apr 10;32(11):1151-6.
  • Ruddy KJ, O'Neill A, Miller KD, Schneider BP, Baker E, Sparano JA, Dang C, Northfelt DW, Sledge GW, Partridge AH.Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.Breast Cancer Res Treat. 2014 Apr;144(3):591-7.
  • Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, Lober WB, Bush NE, Parvathaneni U, Back AL, Amtmann D, Ford R.Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial.J Clin Oncol. 2014 Jan 20;32(3):199-205.
  • Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH.Young Women with Breast Cancer: A Focus Group Study of Unmet Needs.J Adolesc Young Adult Oncol. 2013 Dec 1;2(4):153-160.
  • Ruddy KJ, Gelber S, Tamimi RM, Schapira L, Come SE, Meyer ME, Winer EP, Partridge AH.Breast cancer presentation and diagnostic delays in young women.Cancer. 2014 Jan 1;120(1):20-5.
  • Warner ET, Colditz GA, Palmer JR, Partridge AH, Rosner BA, Tamimi RM.Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?.Breast Cancer Res Treat. 2013 Nov;142(1):165-75.
  • Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ.Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Breast Cancer Res Treat. 2013 Oct;141(3):421-7.
  • Freedman RA, Partridge AH.Management of breast cancer in very young women.Breast. 2013 Aug;22 Suppl 2:S176-9.
  • Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.Ann Intern Med. 2013 Sep 17;159(6):373-81.
  • Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO.Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.Breast. 2013 Oct;22(5):606-15.
  • Cardoso F, Bese N, Distelhorst SR, Bevilacqua JL, Ginsburg O, Grunberg SM, Gralla RJ, Steyn A, Pagani O, Partridge AH, Knaul FM, Aapro MS, Andersen BL, Thompson B, Gralow JR, Anderson BO.Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.Breast. 2013 Oct;22(5):593-605.
  • Partridge AH.Cancer survivorship and the young breast cancer patient: addressing the important issues.Oncologist. 2013;18(8):e19-20.
  • Meisel JL, Economy KE, Calvillo KZ, Schapira L, Tung NM, Gelber S, Kereakoglow S, Partridge AH, Mayer EL.Contemporary multidisciplinary treatment of pregnancy-associated breast cancer.Springerplus. 2013 Dec;2(1):297.
  • Partridge AH, Gelber S, Piccart-Gebhart MJ, Focant F, Scullion M, Holmes E, Winer EP, Gelber RD.Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.J Clin Oncol. 2013 Jul 20;31(21):2692-8.
  • Rosenberg SM, Partridge AH.Premature menopause in young breast cancer: effects on quality of life and treatment interventions.J Thorac Dis. 2013 Jun;5(Suppl 1):S55-61.
  • Bunnell CA, Gross AH, Weingart SN, Kalfin MJ, Partridge A, Lane S, Burstein HJ, Fine B, Hilton NA, Sullivan C, Hagemeister EE, Kelly AE, Colicchio L, Szabatura AH, Winer EP, Salisbury M, Mann S.High performance teamwork training and systems redesign in outpatient oncology.BMJ Qual Saf. 2013 May;22(5):405-13.
  • Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP, Partridge AH.Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ.Oncologist. 2013 Apr 8.
  • Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH.Quality of life and symptoms in male breast cancer survivors.Breast. 2013 Apr;22(2):197-9.
  • Partridge AH, Ruddy KJ, Kennedy J, Winer EP.Model program to improve care for a unique cancer population: young women with breast cancer.J Oncol Pract. 2012 Sep;8(5):e105-10.
  • Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ.Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.J Clin Oncol. 2013 Jan 1;31(1):131-61.
  • Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC, .Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program.Cancer. 2013 Jan 1;119(1):158-63.
  • Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH, .Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.Cancer. 2013 Jan 1;119(1):164-72.
  • Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T.Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.Breast Cancer Res Treat. 2012 Nov 11.
  • Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Kereakoglow S, Borges VF, Come SE, Schapira L, Winer EP, Partridge AH.Body image in recently diagnosed young women with early breast cancer.Psycho Oncology. 2012 Nov 7.
  • Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.Time to diagnosis and breast cancer stage by race/ethnicity.Breast Cancer Res Treat. 2012 Oct 26.
  • Ruddy KJ, Partridge AH.Fertility (male and female) and Menopause.J Clin Oncol. 2012 Oct 20;30(30):3705-11.
  • Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL.Receipt of locoregional therapy among young women with breast cancer.Breast Cancer Res Treat. 2012 Oct;135(3):893-906.
  • Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN.Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery.BMC Med Inform Decis Mak. 2012;12:51.
  • Bober SL, Giobbie-Hurder A, Emmons KM, Winer E, Partridge A.Psychosexual Functioning and Body Image Following a Diagnosis of Ductal Carcinoma In Situ.The Journal Of Sexual Medicine. 2012 Jul 19.
  • Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.The effect of age on delay in diagnosis and stage of breast cancer.Oncologist. 2012;17(6):775-82.
  • Ruddy KJ, Gelber S, Ginsburg ES, Schapira L, Abusief ME, Meyer ME, Partridge AH.Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.Menopause. 2011 Jan;18(1):105-8.
  • Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K.Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].Plast Reconstr Surg. 2011 Jan;127(1):18-26.
  • Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J.Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.Menopause.;17(5):908-16.
  • Partridge AH,Ruddy KJ,Gelber S,Schapira L,Abusief M,Meyer M,Ginsburg E.Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.Fertil Steril. 2010 Jul;94(2):638-44.
  • Peppercorn J, Shapira I, Collyar D, Deshields T, Lin N, Krop I, Grunwald H, Friedman P, Partridge AH, Schilsky RL, Bertagnolli MM.Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.J Clin Oncol. 2010 May 20;28(15):2635-40.
  • Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E, Wolff AC, Wang X, Kastrissios H, Berry D, Hudis C, Winer E, Muss H.Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.J Clin Oncol. 2010 May 10;28(14):2418-22.
  • de Moor JS, Partridge AH, Winer EP, Ligibel J, Emmons KM.The role of socioeconomic status in adjustment after ductal carcinoma in situ.Cancer. 2010 Mar 1;116(5):1218-25.
  • Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH.The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.Cancer. 2010 Feb 15;116(4):791-8.
  • Partridge AH, Winer EP.On mammography--more agreement than disagreement.N Engl J Med. 2009 Dec 24;361(26):2499-501.
  • Sepucha KR,Ozanne EM,Partridge AH,Moy B.Is There a Role for Decision Aids in Advanced Breast Cancer?.Med Decis Making.;29(4):475-82.
  • Ruddy KJ, Partridge AH.Breast cancer in young women: clinical decision-making in the face of uncertainty.Oncology (Huntingt). 2009 May;23(6):474, 477.
  • Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR.Doctor-patient communication about advance directives in metastatic breast cancer.J Palliat Med. 2009 Jun;12(6):547-53.
  • Muss HB,Berry DA,Cirrincione CT,Theodoulou M,Mauer AM,Kornblith AB,Partridge AH,Dressler LG,Cohen HJ,Becker HP,Kartcheske PA,Wheeler JD,Perez EA,Wolff AC,Gralow JR,Burstein HJ,Mahmood AA,Magrinat G,Parker BA,Hart RD,Grenier D,Norton L,Hudis CA,Winer EP.Adjuvant chemotherapy in older women with early-stage breast cancer.N Engl J Med. 2009 May 14;360(20):2055-65.
  • Partridge AH,Winer EP.Sharing study results with trial participants: time for action.J Clin Oncol. 2009 Feb 20;27(6):838-9.
  • Ligibel JA,Partridge A,Giobbie-Hurder A,Golshan M,Emmons K,Winer EP.Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.Ann Surg Oncol. 2009 Jan;16(1):106-12.
  • Partridge A,Winer JP,Golshan M,Bellon JR,Blood E,Dees EC,Sampson E,Emmons KM,Winer E.Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.Clin Breast Cancer. 2008 Jun;8(3):275-80.
  • Peppercorn J,Partridge AH.Breast cancer in young women: a new color or a different shade of pink?.J Clin Oncol. 2008 Jul 10;26(20):3303-5.
  • Partridge AH,Wolff AC,Marcom PK,Kaufman PA,Zhang L,Gelman R,Moore C,Lake D,Fleming GF,Rugo HS,Atkins J,Sampson E,Collyar D,Winer EP.The impact of sharing results of a randomized breast cancer clinical trial with study participants.Breast Cancer Res Treat. 2009 May;115(1):123-9.
  • Partridge AH.Fertility preservation: a vital survivorship issue for young women with breast cancer.J Clin Oncol. 2008 Jun 1;26(16):2612-3.
  • Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP.Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.J Clin Oncol. 2008 Feb 20;26(6):907-12.
  • Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the National Cancer Institute. 2008 Feb 20;100(4):243-51.
  • Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A.Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.J Clin Oncol. 2008 Feb 1;26(4):556-62.
  • Duffy C, Perez K, Partridge A.Implications of phytoestrogen intake for breast cancer.CA Cancer J Clin. 2007 Sep-Oct;57(5):260-77. Review.
  • Partridge AH, Ruddy KJ.Fertility and adjuvant treatment in young women with breast cancer.Breast. 2007 Dec;16 Suppl 2:S175-81. Review.
  • Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E.Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI.Eur J Cancer. 2007 Jul;43(11):1646-53.
  • Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M.Oral chemotherapy safety practices at US cancer centres: questionnaire survey.BMJ. 2007 Feb 24;334(7590):407.
  • Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol. 2006 Nov 20;24(33):5330-1.
  • Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.Menopausal-type symptoms in young breast cancer survivors.Ann Oncol. 2006 Dec;17(12):1777-82.
  • Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Cancer. 2006 Jun;7(2):158-61.
  • , Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K.American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.J Clin Oncol. 2006 Jun 20;24(18):2917-31.
  • Partridge AH.Non-adherence to endocrine therapy for breast cancer.Ann Oncol. 2006 Feb;17(2):183-4.
  • Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8340-7.
  • Peppercorn J, Partridge A, Burstein HJ, Winer EP.Standards for follow-up care of patents with breast cancer.Breast. 2005 Dec;14(6):500-8.
  • Partridge AH.Young women's preferences about adjuvant endocrine therapy for breast cancer.Lancet Oncol. 2005 Aug;6(8):542-4.
  • Simon B, Lee SJ, Partridge AH, Runowicz CD.Preserving fertility after cancer.CA Cancer J Clin. 2005 Jul-Aug;55(4):211-28; quiz 263-4.
  • Partridge A, Schapira L.Pregnancy and breast cancer: epidemiology, treatment, and safety issues.Oncology (Huntingt). 2005 May;19(6):693-7; discussion 697-700.
  • Partridge AH, Winer EP.Fertility after breast cancer: questions abound.J Clin Oncol. 2005 Jul 1;23(19):4259-61.
  • Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP.Offering participants results of a clinical trial: sharing results of a negative study.Lancet. 2005 Mar 12-18;365(9463):963-4.
  • Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP.Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.J Natl Cancer Inst. 2004 Apr 21;96(8):629-32.
  • Partridge AH, Winer EP, Burstein HJ.Follow-up care of breast cancer survivors.Semin Oncol. 2003 Dec;30(6):817-25.
  • Nekhlyudov L, Partridge A.Breast cancer risk communication: challenges and future research directions: workshop report (United States).Cancer Causes Control. 2003 Apr;14(3):235-9.
  • Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP.Do patients participating in clinical trials want to know study results?.J Natl Cancer Inst. 2003 Mar 19;95(6):491-2.
  • Partridge AH, Wang PS, Winer EP, Avorn J.Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol. 2003 Feb 15;21(4):602-6.
  • Partridge AH, Winer EP.Informing clinical trial participants about study results.JAMA. 2002 Jul 17;288(3):363-5.
  • Partridge AH, Avorn J, Wang PS, Winer EP.Adherence to therapy with oral antineoplastic agents.J Natl Cancer Inst. 2002 May 1;94(9):652-61.
  • Burstein HJ, Partridge AH, Lesnikoski BA.Treatment of breast cancer during pregnancy.Expert Opin Pharmacother. 2002 Apr;3(4):423-8.
  • Partridge AH, Bunnell CA, Winer EP.Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.Harrison's Principles of Internal Medicine. 2001 Winter;14:41-50.
  • Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP.Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.J Clin Oncol. 2001 May 15;19(10):2722-30.